Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors
Washington University School of Medicine
Washington University School of Medicine
University of Iowa
Vanderbilt University
Children's Oncology Group
Eli Lilly and Company
Northwestern University